This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical & Medical Affairs
search

Using Wearables in Clinical Trials: Going Beyond the Hype - WHITEPAPER

ArticleImage

Download the exclusive whitepaper

Mobile devices like smartphones and its wide range of body sensors, can streamline the collection of distinctive real-life and long-term data. There is a growing recognition, among clinicians, researchers and funders, that digital phenotyping can provide invaluable additional data from patients using technology that is already used for personal reasons by the majority of us. Collecting dense data from trial participants using wearables in natural settings - often not collectible otherwise - may fundamentally change how clinical trials are designed and conducted. However, researchers face many challenges in the clinic, from scientific procedures to regulatory, legal, and operational difficulties.

This whitepaper looks at case studies of wearables being used successfully in clinical trials and how they have overcome these challenges.

To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.

Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.


 

ABOUT THE AUTHOR: Dr Catarina Carrao gained a PhD in Biochemistry from Northeastern Ohio Medical and Pharmacy University and an M.Phil in Biochemistry at the University of Beira Interior. She has worked as a researcher at Max F. Perutz Laboratories, Yale Cardiovascular Center at Yale University School of Medicine, and the Center Cardiovascular Research (CCR) at Charité Medical University.

Log in or Create an Informa Connect Account to Access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.